AI-designed drug shows early biological-age signal in small trial
NDTV Profit reported that rentosertib, an AI-designed drug tested for lung disease, was associated with lower biological-age estimates in a reanalysis of blood samples from 42 patients. The finding is preliminary and has not been independently confirmed here.